Study Evaluating Sorafenib Added to Standard Primary Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Less Than 60 Years of Age
Clinical trial NCT00893373 · COMPLETED
Trial details
- NCT number
- NCT00893373
- Sponsor
- Technische Universität Dresden
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2011-11-01
- Enrollment
- 276
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.